Envoy Medical, Inc.
COCH
$1.38
$0.010.73%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -30.00% | 7.94% | -24.36% | 375.00% | 40.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -30.00% | 7.94% | -24.36% | 375.00% | 40.35% |
| Cost of Revenue | -1.06% | 51.23% | -12.57% | 54.97% | 78.30% |
| Gross Profit | -20.18% | -78.79% | 3.09% | -6.11% | -122.45% |
| SG&A Expenses | 46.28% | -6.10% | 39.90% | 165.84% | 75.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.17% | 8.47% | 28.79% | 133.42% | 86.99% |
| Operating Income | -46.94% | -8.48% | -29.89% | -131.76% | -88.47% |
| Income Before Tax | -481.32% | 70.20% | 52.69% | 57.47% | 216.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -481.32% | 70.20% | 52.69% | 57.47% | 216.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -481.32% | 70.20% | 52.69% | 57.47% | 216.73% |
| EBIT | -46.94% | -8.48% | -29.89% | -131.76% | -88.47% |
| EBITDA | -46.75% | -8.25% | -29.91% | -132.19% | -89.18% |
| EPS Basic | -381.14% | 79.29% | 70.25% | 78.20% | 200.60% |
| Normalized Basic EPS | 7.05% | 84.61% | 16.46% | 198.71% | -147.04% |
| EPS Diluted | -398.88% | 79.29% | 70.27% | 78.12% | 194.63% |
| Normalized Diluted EPS | -2.04% | 84.61% | 16.46% | 198.71% | -125.03% |
| Average Basic Shares Outstanding | 92.05% | 93.63% | 93.63% | 95.11% | 0.90% |
| Average Diluted Shares Outstanding | 74.91% | 93.63% | 93.63% | 95.11% | 10.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
